News
-
-
COMMUNIQUÉ DE PRESSE
Evotec and Odyssey Therapeutics Enter AI-Enabled R&D Collaboration in Autoimmune and Inflammatory Diseases
Evotec SE and Odyssey Therapeutics collaborate on AI-enabled R&D for autoimmune and inflammatory diseases, aiming to discover new treatments. Collaboration combines expertise and technology to accelerate drug discovery -
-
-
COMMUNIQUÉ DE PRESSE
Instone Group: Strong operating cash flow in H1; geopolitical uncertainties dampen the recovery in demand
Instone Real Estate Group SE reports strong operating cash flow in H1 2026 despite geopolitical uncertainties affecting demand. Joint venture with Ginkgo signed for Düsseldorf-Benrath project -
-
COMMUNIQUÉ DE PRESSE
Deutsche Beteiligungs AG: Strong transaction activity in H1; forecast adjusted due to valuation multiples
Deutsche Beteiligungs AG reports strong transaction activity in H1, adjusting forecast due to valuation multiples. 26.1 million euros returned to shareholders; NAV per share at 33.65 euros -
-
COMMUNIQUÉ DE PRESSE
DEUTZ generates double-digit growth in the first half of 2026 – 2030 targets will be achieved significantly earlier thanks to a billion-euro transaction
DEUTZ achieves double-digit growth in the first half of 2026, meeting 2030 targets earlier with a billion-euro acquisition. New orders up 29%, revenue rises 11%, EBIT rises 43% -
COMMUNIQUÉ DE PRESSE
Order book reaches record of €473.7 million, providing strong visibility for 2027
SUSS MicroTec SE reports record order book of €473.7 million in Half-Yearly Financial Report 2026, highlighting strong visibility for 2027. Sales reach €202.8 million in the first half with profitability improvements
